Assisted reproductive technology: what are the cardiovascular risks for women?

References

• Practice Committee of the American society for reproductive M. Diagnostic evaluation of the infertile female: a committee opinion. Fertil Steril. 2015;103(6):e44–50. doi: 10.1016/j.fertnstert.2015.03.019
   PubMed Web of Science ®Google Scholar
• Wu P, Sharma GV, Mehta LS, et al. In-Hospital complications in pregnancies conceived by assisted reproductive technology. J Am Heart Assoc. 2022;11(5):e022658. doi: 10.1161/JAHA.121.022658
   PubMed Web of Science ®Google Scholar
• Brugo-Olmedo S, Chillik C, Kopelman S. Definition and causes of infertility. Reprod Biomed Online. 2001;2(1):41–53. doi: 10.1016/S1472-6483(10)62187-6
   PubMedGoogle Scholar
• Carson SA, Kallen AN. Diagnosis and management of infertility: a review. JAMA. 2021;326(1):65–76. doi: 10.1001/jama.2021.4788
   PubMed Web of Science ®Google Scholar
• Van Voorhis BJ. Clinical practice. In vitro fertilization. N Engl J Med. 2007;356(4):379–386. doi: 10.1056/NEJMcp065743
   PubMed Web of Science ®Google Scholar
• Smith J, Velez MP, Dayan N. Infertility, infertility treatment, and cardiovascular disease: an overview. Can J Cardiol. 2021;37(12):1959–1968. doi: 10.1016/j.cjca.2021.09.002
   PubMed Web of Science ®Google Scholar
• Jain M, Singh M. Assisted Reproductive Technology (ART) Techniques. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan. Available from: https://www.ncbi.nlm.nih.gov/books/NBK576409/
   Google Scholar
• RCW M, NYH N, Cheung LP. Assisted reproduction technology and long-term cardiometabolic health in the offspring. PLOS Med. 2021;18(9):e1003724. doi: 10.1371/journal.pmed.1003724
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. State-specific assisted reproductive technology surveillance. https://www.cdc.gov/art/state-specific-surveillance/index.html [Accessed Jan 29, 2023].
   Google Scholar
• Tsao CW, Aday AW, Almarzooq ZI, et al. Heart disease and stroke statistics-2023 Update: a report from the American Heart association. Circulation. 2023;147(8):e93–e621. doi: 10.1161/CIR.0000000000001123
   PubMed Web of Science ®Google Scholar
• Vogel B, Acevedo M, Appelman Y, et al. The Lancet women and cardiovascular disease commission: reducing the global burden by 2030. Lancet. 2021;397(10292):2385–2438. doi: 10.1016/S0140-6736(21)00684-X
   PubMed Web of Science ®Google Scholar
• Creanga AA, Syverson C, Seed K, et al. Pregnancy-related mortality in the United States, 2011-2013. Obstet Gynecol. 2017;130(2):366–373. doi: 10.1097/AOG.0000000000002114
   PubMed Web of Science ®Google Scholar
• O’Kelly AC, Michos ED, Shufelt CL, et al. Pregnancy and reproductive risk factors for cardiovascular disease in women. Circ Res. 2022;130(4):652–672. doi: 10.1161/CIRCRESAHA.121.319895
   PubMed Web of Science ®Google Scholar
• Mulder CL, Lassi ZS, Grieger JA, et al. Cardio-metabolic risk factors among young infertile women: a systematic review and meta-analysis. BJOG. 2020;127(8):930–939. doi: 10.1111/1471-0528.16171
   PubMed Web of Science ®Google Scholar
• Mahalingaiah S, Sun F, Cheng JJ, et al. Cardiovascular risk factors among women with self-reported infertility. Fertil Res And Pract. 2017;3(1):7. doi: 10.1186/s40738-017-0034-0
   PubMedGoogle Scholar
• American College of Obstetrics and Gynecologists. Committee on practice bulletins-gynecology. ACOG Practice Bulletin No. 194: Polycystic Ovary Syndrome. Obstet Gynecol. 2018;131(6):e157–e171. doi: 10.1097/AOG.0000000000002656
   PubMed Web of Science ®Google Scholar
• Zahid S, Khan MZ, Gowda S, et al. Trends, predictors, and outcomes of cardiovascular complications associated with polycystic ovary syndrome during delivery hospitalizations: a National inpatient sample analysis (2002–2019). J Am Heart Assoc. 2022;11(16):e025839. doi: 10.1161/JAHA.121.025839
   PubMed Web of Science ®Google Scholar
• Osibogun O, Ogunmoroti O, Michos ED. Polycystic ovary syndrome and cardiometabolic risk: opportunities for cardiovascular disease prevention. Trends Cardiovasc Med. 2020;30(7):399–404. doi: 10.1016/j.tcm.2019.08.010
   PubMed Web of Science ®Google Scholar
• Guan C, Zahid S, Minhas AS, et al. Polycystic ovary syndrome: a “risk-enhancing” factor for cardiovascular disease. Fertil Steril. 2022;117(5):924–935. doi: 10.1016/j.fertnstert.2022.03.009
   PubMed Web of Science ®Google Scholar
• Wild RA, Rizzo M, Clifton S, et al. Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis. Fertil Steril. 2011;95(3):1073-9 e1–11. doi: 10.1016/j.fertnstert.2010.12.027
   Web of Science ®Google Scholar
• Joham AE, Kakoly NS, Teede HJ, et al. Incidence and predictors of hypertension in a cohort of Australian women with and without polycystic ovary syndrome. J Clin Endocrinol Metab. 2021;106(6):1585–1593. doi: 10.1210/clinem/dgab134
   PubMed Web of Science ®Google Scholar
• Moran LJ, Misso ML, Wild RA, et al. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2010;16(4):347–363. doi: 10.1093/humupd/dmq001
   PubMed Web of Science ®Google Scholar
• Kovell LC, Juraschek SP, Michos ED. Hypertension in young women: implications of the polycystic ovary syndrome and opportunities for prevention and further research. J Clin Endocrinol Metab. 2021;106(9):e3775–e3777. doi: 10.1210/clinem/dgab345
   PubMed Web of Science ®Google Scholar
• Lim SS, Davies MJ, Norman RJ, et al. Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2012;18(6):618–637. doi: 10.1093/humupd/dms030
   PubMed Web of Science ®Google Scholar
• Talbott EO, Zborowski JV, Rager JR, et al. Evidence for an association between metabolic cardiovascular syndrome and coronary and aortic calcification among women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2004;89(11):5454–5461. doi: 10.1210/jc.2003-032237
   PubMed Web of Science ®Google Scholar
• Calderon-Margalit R, Siscovick D, Merkin SS, et al. Prospective association of polycystic ovary syndrome with coronary artery calcification and carotid-intima-media thickness: the coronary artery risk development in young adults women’s study. Arterioscler Thromb Vasc Biol. 2014;34(12):2688–2694. doi: 10.1161/ATVBAHA.114.304136
   PubMed Web of Science ®Google Scholar
• Osibogun O, Ogunmoroti O, Kolade OB, et al. A systematic review and meta-analysis of the association between polycystic ovary syndrome and coronary artery calcification. J Womens Health. 2022;31(6):762–771. doi: 10.1089/jwh.2021.0608
   Web of Science ®Google Scholar
• El Hayek S, Bitar L, Hamdar LH, et al. Poly cystic ovarian syndrome: an updated overview. Front Physiol. 2016;7:124. doi: 10.3389/fphys.2016.00124
   PubMed Web of Science ®Google Scholar
• Bulun SE. Endometriosis. N Engl J Med. 2009;360(3):268–279. doi: 10.1056/NEJMra0804690
   PubMed Web of Science ®Google Scholar
• Melo AS, Rosa-E-Silva JC, Rosa-E-Silva AC, et al. Unfavorable lipid profile in women with endometriosis. Fertil Steril. 2010;93(7):2433–2436. doi: 10.1016/j.fertnstert.2009.08.043
   PubMed Web of Science ®Google Scholar
• Bedaiwy MA, Falcone T, Sharma RK, et al. Prediction of endometriosis with serum and peritoneal fluid markers: a prospective controlled trial. Hum Reprod. 2002;17(2):426–431. doi: 10.1093/humrep/17.2.426
   PubMed Web of Science ®Google Scholar
• Agic A, Xu H, Finas D, et al. Is endometriosis associated with systemic subclinical inflammation? Gynecol Obstet Invest. 2006;62(3):139–147. doi: 10.1159/000093121
   PubMed Web of Science ®Google Scholar
• Zahid S, Hashem A, Minhas AS, et al. Cardiovascular complications during delivery admissions associated with assisted reproductive technology (from a National inpatient sample analysis 2008 to 2019). Am J Cardiol. 2023;186:126–134. doi: 10.1016/j.amjcard.2022.08.037
   PubMed Web of Science ®Google Scholar
• Udell JA, Lu H, Redelmeier DA. Long-term cardiovascular risk in women prescribed fertility therapy. J Am Coll Cardiol. 2013;62(18):1704–1712. doi: 10.1016/j.jacc.2013.05.085
   PubMed Web of Science ®Google Scholar
• Luke B, Gopal D, Cabral H, et al. Adverse pregnancy, birth, and infant outcomes in twins: effects of maternal fertility status and infant gender combinations; the Massachusetts outcomes study of assisted reproductive technology. Am J Obstet Gynecol. 2017;217(3):e3301–e33015. doi: 10.1016/j.ajog.2017.04.025
   Web of Science ®Google Scholar
• Henriksson P. Cardiovascular problems associated with IVF therapy. J Intern Med. 2021;289(1):2–11. doi: 10.1111/joim.13136
   PubMed Web of Science ®Google Scholar
• Alper MM, Fauser BC. Ovarian stimulation protocols for IVF: is more better than less? Reprod Biomed Online. 2017;34(4):345–353. doi: 10.1016/j.rbmo.2017.01.010
   PubMed Web of Science ®Google Scholar
• Dayan N, Filion KB, Okano M, et al. Cardiovascular risk following fertility therapy: systematic review and meta-analysis. J Am Coll Cardiol. 2017;70(10):1203–1213. doi: 10.1016/j.jacc.2017.07.753
   PubMed Web of Science ®Google Scholar
• Sealey JE, Itskovitz-Eldor J, Rubattu S, et al. Estradiol- and progesterone-related increases in the renin-aldosterone system: studies during ovarian stimulation and early pregnancy. J Clin Endocrinol Metab. 1994;79(1):258–264. doi: 10.1210/jcem.79.1.8027239
   PubMed Web of Science ®Google Scholar
• Practice Committee of American Society for Reproductive Medicine. Ovarian hyperstimulation syndrome. Fertil Steril. 2008;90(5 Suppl):S188–93. doi: 10.1016/j.fertnstert.2008.08.034
   PubMed Web of Science ®Google Scholar
• Singh B, Reschke L, Segars J, et al. Frozen-thawed embryo transfer: the potential importance of the corpus luteum in preventing obstetrical complications. Fertil Steril. 2020;113(2):252–257. doi: 10.1016/j.fertnstert.2019.12.007
   PubMed Web of Science ®Google Scholar
• Meah VL, Cockcroft JR, Backx K, et al. Cardiac output and related haemodynamics during pregnancy: a series of meta-analyses. Heart. 2016 Apr;102(7):518–526. doi: 10.1136/heartjnl-2015-308476
   PubMed Web of Science ®Google Scholar
• Sanghavi M, Rutherford JD. Cardiovascular physiology of pregnancy. Circulation. 2014;130(12):1003–1008. doi: 10.1161/CIRCULATIONAHA.114.009029
   PubMed Web of Science ®Google Scholar
• Kametas NA, McAuliffe F, Krampl E, et al. Maternal cardiac function in twin pregnancy. Obstet Gynecol. 2003;102(4):806–815. doi: 10.1097/00006250-200310000-00024
   PubMed Web of Science ®Google Scholar
• Qureshi AI, Saeed O, Malik AA, et al. Pregnancy in advanced age and the risk of stroke in postmenopausal women: analysis of women’s Health initiative study. Am J Obstet Gynecol. 2017;216(4):e409 1–e409 6. doi: 10.1016/j.ajog.2016.12.004
   Web of Science ®Google Scholar
• American College of Obstetrics and Gynecologists’ Committee on Clinical Consensus-Obstretrics, Gantt A, Metz TD, et al. Obstetric care consensus #11, pregnancy at age 35 years or older. Am J Obstet Gynecol. 2023;228(3):B25–B40.
   PubMed Web of Science ®Google Scholar
• Grandone E, Ageno W. The legacy of Edwards and Steptoe and the windy roads of assisted reproduction: where do we stand with venous thromboembolism? Thromb Haemost. 2023;123(3):267–269. doi: 10.1055/a-1996-1341
   PubMedGoogle Scholar
• Goualou M, Noumegni S, de Moreuil C, et al. Venous thromboembolism associated with assisted reproductive technology: a systematic review and meta-analysis. Thromb Haemost. 2023;123(3):283–294. doi: 10.1055/s-0042-1760255
   PubMedGoogle Scholar
• Sennstrom M, Rova K, Hellgren M, et al. Thromboembolism and in vitro fertilization - a systematic review. Acta Obstet Gynecol Scand. 2017;96(9):1045–1052. doi: 10.1111/aogs.13147
   PubMed Web of Science ®Google Scholar
• Olausson N, Discacciati A, Nyman AI, et al. Incidence of pulmonary and venous thromboembolism in pregnancies after in vitro fertilization with fresh respectively frozen-thawed embryo transfer: nationwide cohort study. J Thromb Haemost. 2020;18(8):1965–1973. doi: 10.1111/jth.14840
   PubMed Web of Science ®Google Scholar
• Kulkarni AD, Jamieson DJ, Jones HW Jr., et al. Fertility treatments and multiple births in the United States. N Engl J Med. 2013;369(23):2218–2225. doi: 10.1056/NEJMoa1301467
   PubMed Web of Science ®Google Scholar
• Behrens I, Basit S, Lykke JA, et al. Hypertensive disorders of pregnancy and peripartum cardiomyopathy: a nationwide cohort study. PLoS One. 2019;14(2):e0211857. doi: 10.1371/journal.pone.0211857
   PubMed Web of Science ®Google Scholar
• Bergman L, Nordlof-Callbo P, Wikstrom AK, et al. Multi-fetal pregnancy, preeclampsia, and long-term cardiovascular disease. Hypertension. 2020;76(1):167–175. doi: 10.1161/HYPERTENSIONAHA.120.14860
   PubMed Web of Science ®Google Scholar
• Cho GJ, Jung US, Kim HY, et al. Women with multiple gestations have an increased risk of development of hypertension in the future. Bmc Pregnancy Childbirth. 2021;21(1):510. doi: 10.1186/s12884-021-03992-2
   PubMed Web of Science ®Google Scholar
• Katler QS, Kawwass JF, Hurst BS, et al. Vanquishing multiple pregnancy in in vitro fertilization in the United States-a 25-year endeavor. Am J Obstet Gynecol. 2022;227(2):129–135. doi: 10.1016/j.ajog.2022.02.005
   PubMed Web of Science ®Google Scholar
• Peterson SH, Westvik-Johari K, Spangmose AL, et al. Risk of hypertensive disorders in pregnancy after fresh and frozen embryo transfer in assisted reproduction: a population-based cohort study with Within-Sibship analysis. Hypertension. 2023;80(2):e6–e16. doi: 10.1161/HYPERTENSIONAHA.122.19689
   PubMed Web of Science ®Google Scholar
• Conrad KP, von Versen-Höynck F, Baker VL. Potential role of the corpus luteum in maternal cardiovascular adaptation to pregnancy and preeclampsia risk. Am J Obstet Gynecol. 2022;226(5):683–699. doi: 10.1016/j.ajog.2021.08.018
   PubMed Web of Science ®Google Scholar
• Verit FF, Yildiz Zeyrek F, Zebitay AG, et al. Cardiovascular risk may be increased in women with unexplained infertility. Clin Exp Reprod Med. 2017;44(1):28–32. doi: 10.5653/cerm.2017.44.1.28
   PubMedGoogle Scholar
• Parikh NI, Cnattingius S, Mittleman MA, et al. Subfertility and risk of later life maternal cardiovascular disease. Hum Reprod. 2012;27(2):568–575. doi: 10.1093/humrep/der400
   PubMed Web of Science ®Google Scholar
• Lau ES, Wang D, Roberts M, et al. Infertility and risk of Heart failure in the women’s Health initiative. J Am Coll Cardiol. 2022;79(16):1594–1603. doi: 10.1016/j.jacc.2022.02.020
   PubMed Web of Science ®Google Scholar
• Parikh NI, Jeppson RP, Berger JS, et al. Reproductive risk factors and coronary Heart disease in the women’s Health initiative observational study. Circulation. 2016;133(22):2149–2158. doi: 10.1161/CIRCULATIONAHA.115.017854
   PubMed Web of Science ®Google Scholar
• Cairncross ZF, Ahmed SB, Dumanski SM, et al. Infertility and the risk of cardiovascular disease: findings from the study of women’s Health across the Nation (SWAN). CJC Open. 2021;3(4):400–408. doi: 10.1016/j.cjco.2020.11.011
   PubMedGoogle Scholar
• Scicchitano P, Dentamaro I, Carbonara R, et al. Cardiovascular risk in women with PCOS. Int J Endocrinol Metab. 2012;10(4):611–618. doi: 10.5812/ijem.4020
   PubMedGoogle Scholar
• Okoth K, Chandan JS, Marshall T, et al. Association between the reproductive health of young women and cardiovascular disease in later life: umbrella review. BMJ. 2020;371:m3502. doi: 10.1136/bmj.m3502
   PubMed Web of Science ®Google Scholar
• Mu F, Rich-Edwards J, Rimm EB, et al. Endometriosis and risk of coronary Heart disease. Circ Cardiovasc Qual Outcomes. 2016;9(3):257–264. doi: 10.1161/CIRCOUTCOMES.115.002224
   PubMed Web of Science ®Google Scholar
• Magnus MC, Fraser A, Haberg SE, et al. Maternal risk of cardiovascular disease after use of assisted reproductive technologies. JAMA Cardiol. 2023;8(9):837–845. doi: 10.1001/jamacardio.2023.2324
   PubMedGoogle Scholar
• Levine AD, Boulet SL, Kissin DM. Contribution of assisted reproductive technology to overall births by maternal age in the United States, 2012-2014. JAMA. 2017;317(12):1272–1273. doi: 10.1001/jama.2016.21311
   PubMed Web of Science ®Google Scholar
• Grandi SM, Filion KB, Yoon S, et al. Cardiovascular disease-related morbidity and mortality in women with a history of pregnancy complications. Circulation. 2019;139(8):1069–1079. doi: 10.1161/CIRCULATIONAHA.118.036748
   PubMed Web of Science ®Google Scholar
• Haug EB, Horn J, Markovitz AR, et al. Association of conventional cardiovascular risk factors with cardiovascular disease after hypertensive disorders of pregnancy: analysis of the nord-trondelag Health study. JAMA Cardiol. 2019;4(7):628–635. doi: 10.1001/jamacardio.2019.1746
   PubMed Web of Science ®Google Scholar
• Germain AM, Romanik MC, Guerra I, et al. Endothelial dysfunction: a link among preeclampsia, recurrent pregnancy loss, and future cardiovascular events? Hypertension. 2007;49(1):90–95. doi: 10.1161/01.HYP.0000251522.18094.d4
   PubMed Web of Science ®Google Scholar
• Hermes W, Ket JC, van Pampus MG, et al. Biochemical cardiovascular risk factors after hypertensive pregnancy disorders: a systematic review and meta-analysis. Obstet Gynecol Surv. 2012;67(12):793–809. doi: 10.1097/OGX.0b013e31827682fc
   PubMed Web of Science ®Google Scholar
• Choi E, Kazzi B, Varma B, et al. The fourth trimester: a time for enhancing transitions in cardiovascular care. Curr Cardiovasc Risk Rep. 2022;16(12):219–229. doi: 10.1007/s12170-022-00706-x
   PubMed Web of Science ®Google Scholar
• Goldstein KM, Callegari LS. Should a history of assisted reproductive technology be another consideration when assessing cardiovascular risk? J Clin Hypertens (Greenwich). 2017;19(2):170–172. doi: 10.1111/jch.12937
   PubMed Web of Science ®Google Scholar
• Oza-Frank R, Gilson E, Keim SA, et al. Trends and factors associated with self-reported receipt of preconception care: PRAMS, 2004-2010. Birth. 2014;41(4):367–373. doi: 10.1111/birt.12122
   PubMed Web of Science ®Google Scholar
• Teede HJ, Misso ML, Costello MF, et al. Erratum. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2019;34(2):388. doi: 10.1093/humrep/dey363
   PubMed Web of Science ®Google Scholar
• Parikh NI, Gonzalez JM, Anderson CAM, et al. Adverse pregnancy outcomes and cardiovascular disease risk: Unique opportunities for cardiovascular disease prevention in women: a scientific statement from the American Heart association. Circulation. 2021;143(18):e902–e916. doi: 10.1161/CIR.0000000000000961
   PubMed Web of Science ®Google Scholar
• ACOG Practice Bulletin No. ACOG practice Bulletin no. 212 summary: pregnancy and Heart disease. Obstet Gynecol. 2019;133(5):1067–1072. doi: 10.1097/AOG.0000000000003244
   PubMedGoogle Scholar
• Jowell AR, Sarma AA, Gulati M, et al. Interventions to mitigate risk of cardiovascular disease after adverse pregnancy outcomes: a review. JAMA Cardiol. 2022;7(3):346–355. doi: 10.1001/jamacardio.2021.4391
   PubMed Web of Science ®Google Scholar
• Arnett DK, Blumenthal RS, Albert MA, et al. ACC/AHA guideline on the primary prevention of cardiovascular disease: Executive summary: a report of the American College of Cardiology/American Heart association task force on clinical practice guidelines. J Am Coll Cardiol. 2019;74(10):1376–1414. doi: 10.1016/j.jacc.2019.03.009
   PubMed Web of Science ®Google Scholar
• Elder P, Sharma G, Gulati M, et al. Identification of female-specific risk enhancers throughout the lifespan of women to improve cardiovascular disease prevention. Am J Prev Cardiol. 2020;2:100028. doi: 10.1016/j.ajpc.2020.100028
   PubMedGoogle Scholar
• Michos ED, Blaha MJ, Blumenthal RS. Use of the coronary artery calcium score in discussion of initiation of statin therapy in primary prevention. Mayo Clin Proceed. 2017;92(12):1831–1841. doi: 10.1016/j.mayocp.2017.10.001
   PubMed Web of Science ®Google Scholar
• Park K, Wu P, Gulati M. Obstetrics and gynecological history: a missed opportunity for cardiovascular risk assessment. JACC Case Rep. 2020;2(1):161–163. doi: 10.1016/j.jaccas.2019.11.035
   PubMedGoogle Scholar
• Brown HL, Warner JJ, Gianos E, et al. Promoting risk identification and reduction of cardiovascular disease in women through collaboration with obstetricians and Gynecologists: a presidential advisory from the American Heart association and the American College of obstetricians and Gynecologists. Circulation. 2018;137(24):e843–e852. doi: 10.1161/CIR.0000000000000582
   PubMed Web of Science ®Google Scholar
• Hypertension in pregnancy. Report of the American College of obstetricians and Gynecologists’ task force on hypertension in pregnancy. Obstet Gynecol. 2013;122(5):1122–1131. doi: 10.1097/01.AOG.0000437382.03963.88
   PubMed Web of Science ®Google Scholar
• Tita AT, Szychowski JM, Boggess K, et al. Treatment for mild chronic hypertension during pregnancy. N Engl J Med. 2022;386(19):1781–1792. doi: 10.1056/NEJMoa2201295
   PubMed Web of Science ®Google Scholar
• Davidson KW, Barry MJ, Mangione CM, et al. Aspirin use to prevent preeclampsia and related morbidity and mortality: US preventive services task force recommendation statement. JAMA. 2021;326(12):1186–1191. doi: 10.1001/jama.2021.14781
   PubMed Web of Science ®Google Scholar
• James AH. Venous thromboembolism in pregnancy. Arterioscler Thromb Vasc Biol. 2009;29(3):326–331. doi: 10.1161/ATVBAHA.109.184127
   PubMed Web of Science ®Google Scholar
• Ference BA, Ginsberg HN, Graham I, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European atherosclerosis society consensus panel. Eur Heart J. 2017;38(32):2459–2472. doi: 10.1093/eurheartj/ehx144
   PubMed Web of Science ®Google Scholar
• Cholesterol Treatment Trialists Collaboration. Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials. Lancet 2015;385(9976):1397–1405.
   PubMed Web of Science ®Google Scholar
• Committee W, Lloyd-Jones DM, Morris PB, et al. ACC Expert consensus decision pathway on the role of nonstatin therapies for LDL-Cholesterol lowering in the management of atherosclerotic cardiovascular disease risk: a report of the American College of Cardiology solution set oversight Committee. J Am Coll Cardiol. 2022;80(14):1366–1418. doi: 10.1016/j.jacc.2022.07.006
   PubMed Web of Science ®Google Scholar
• ElSayed NA, Aleppo G, Aroda VR, et al. 10. Cardiovascular disease and risk management: standards of care in diabetes-2023. Diabetes Care. 2023;46(Suppl 1):S158–S190. doi: 10.2337/dc23-S010
   PubMedGoogle Scholar
• Das SR, Everett BM, Birtcher KK, et al. Expert consensus decision pathway on novel therapies for cardiovascular risk reduction in patients with type 2 diabetes: a report of the American College of Cardiology solution set oversight committee. J Am Coll Cardiol. 2020;76(9):1117–1145. doi: 10.1016/j.jacc.2020.05.037
   PubMed Web of Science ®Google Scholar
• Sattar N, Lee MMY, Kristensen SL, et al. Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials. Lancet Diabetes Endocrinol. 2021;9(10):653–662. doi: 10.1016/S2213-8587(21)00203-5
   PubMed Web of Science ®Google Scholar
• Bhattarai M, Salih M, Regmi M, et al. Association of sodium-glucose Cotransporter 2 inhibitors with cardiovascular outcomes in patients with type 2 diabetes and other risk factors for cardiovascular disease: a meta-analysis. JAMA Netw Open. 2022;5(1):e2142078. doi: 10.1001/jamanetworkopen.2021.42078
   PubMed Web of Science ®Google Scholar
• Siamashvili M, Davis SN. Update on the effects of GLP-1 receptor agonists for the treatment of polycystic ovary syndrome. Expert Rev Clin Pharmacol. 2021;14(9):1081–1089. doi: 10.1080/17512433.2021.1933433
   PubMed Web of Science ®Google Scholar
• Alghrani A. The human fertilisation and embryology act 2008: a missed opportunity? J Med Ethics. 2009;35(12):718–719. doi: 10.1136/jme.2009.033365
   PubMed Web of Science ®Google Scholar